CIK 0001799448 · Non-accelerated filer<br>Smaller reporting company
Aligos Therapeutics, Inc.
Sign in to watch- Ticker
- ALGS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (800) 466-6059
- Business address
- ONE CORPORATE DR., 2ND FLOOR, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-28 | Symons Julian A. See Remarks | Grant or award · Stock Option (Right to Buy) | +21,693 | 21,693 | ||
| 2025-02-28 | Calhoun Lesley Ann See Remarks | Grant or award · Stock Option (Right to Buy) | +47,271 | 47,271 | ||
| 2024-10-08 | Achneck Hardean Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2024-09-04 | Calhoun Lesley Ann See Remarks | Grant or award · Stock Option (Right to Buy) | +10,880 | 10,880 | ||
| 2024-09-04 | BLATT LAWRENCE Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +33,920 | 33,920 | ||
| 2024-09-04 | Symons Julian A. See Remarks | Grant or award · Stock Option (Right to Buy) | +10,880 | 10,880 | ||
| 2024-08-07 | Chavez Margarita Director | Grant or award · Stock Option (Right to Buy) | +120,000 | 120,000 | ||
| 2024-08-07 | Preston Heather Director | Grant or award · Stock Option (Right to Buy) | +120,000 | 120,000 | ||
| 2024-06-27 | Hirth Peter Director | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2024-06-27 | Nuechterlein Carole Director | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2024-06-27 | Scopa James Paul Director | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2024-06-27 | Martell Bridget A Director | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2024-03-01 | McClure Matthew W. Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +72,000 | 72,000 | ||
| 2024-03-01 | Calhoun Lesley Ann See Remarks | Grant or award · Stock Option (Right to Buy) | +308,940 | 308,940 | ||
| 2024-03-01 | Symons Julian A. See Remarks | Grant or award · Stock Option (Right to Buy) | +72,000 | 72,000 | ||
| 2024-03-01 | BLATT LAWRENCE Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +965,435 | 965,435 | ||
| 2024-02-28 | Hirth Peter Director | Grant or award · Stock Option (Right to Buy) | +4,411 | 4,411 | ||
| 2024-02-28 | Scopa James Paul Director | Grant or award · Stock Option (Right to Buy) | +8,823 | 8,823 | ||
| 2024-02-28 | McClure Matthew W. Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +75,183 | 75,183 | ||
| 2024-02-28 | McClure Matthew W. Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +65,713 | 65,713 |
Page 2 of 12 · 238 trades